BE554749A - - Google Patents
Info
- Publication number
- BE554749A BE554749A BE554749DA BE554749A BE 554749 A BE554749 A BE 554749A BE 554749D A BE554749D A BE 554749DA BE 554749 A BE554749 A BE 554749A
- Authority
- BE
- Belgium
- Prior art keywords
- mice
- compound
- antigens
- virus
- infectious
- Prior art date
Links
- 241000699670 Mus sp. Species 0.000 claims description 72
- 241000700605 Viruses Species 0.000 claims description 56
- 238000000034 method Methods 0.000 claims description 28
- 239000000427 antigen Substances 0.000 claims description 27
- 102000036639 antigens Human genes 0.000 claims description 27
- 108091007433 antigens Proteins 0.000 claims description 27
- 230000002458 infectious effect Effects 0.000 claims description 26
- 244000005700 microbiome Species 0.000 claims description 26
- 208000015181 infectious disease Diseases 0.000 claims description 25
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 20
- 239000012153 distilled water Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- OTIXUSNHAKOJBX-UHFFFAOYSA-N 1-(aziridin-1-yl)ethanone Chemical compound CC(=O)N1CC1 OTIXUSNHAKOJBX-UHFFFAOYSA-N 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 14
- 241000894006 Bacteria Species 0.000 claims description 9
- 239000000725 suspension Substances 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 7
- 239000007900 aqueous suspension Substances 0.000 claims description 7
- 210000004556 brain Anatomy 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 241000700199 Cavia porcellus Species 0.000 claims description 5
- 208000000474 Poliomyelitis Diseases 0.000 claims description 5
- 210000000278 spinal cord Anatomy 0.000 claims description 3
- 241000283073 Equus caballus Species 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 239000003223 protective agent Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 238000002360 preparation method Methods 0.000 description 34
- 239000000243 solution Substances 0.000 description 30
- 229960005486 vaccine Drugs 0.000 description 24
- 239000007788 liquid Substances 0.000 description 22
- 239000000203 mixture Substances 0.000 description 21
- 238000002347 injection Methods 0.000 description 19
- 239000007924 injection Substances 0.000 description 19
- 231100000419 toxicity Toxicity 0.000 description 18
- 230000001988 toxicity Effects 0.000 description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
- 239000000284 extract Substances 0.000 description 10
- 229930006000 Sucrose Natural products 0.000 description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 9
- 239000005720 sucrose Substances 0.000 description 9
- 230000004083 survival effect Effects 0.000 description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000004090 dissolution Methods 0.000 description 8
- 230000036449 good health Effects 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 239000003708 ampul Substances 0.000 description 7
- 230000000890 antigenic effect Effects 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 235000013601 eggs Nutrition 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000011081 inoculation Methods 0.000 description 7
- OXJUJQDEISSCTB-UHFFFAOYSA-N but-3-en-2-imine Chemical compound CC(=N)C=C OXJUJQDEISSCTB-UHFFFAOYSA-N 0.000 description 6
- 231100000518 lethal Toxicity 0.000 description 6
- 230000001665 lethal effect Effects 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 238000007710 freezing Methods 0.000 description 5
- 230000008014 freezing Effects 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000003000 nontoxic effect Effects 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000000415 inactivating effect Effects 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000002255 vaccination Methods 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 230000004520 agglutination Effects 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 241000712461 unidentified influenza virus Species 0.000 description 3
- 208000000832 Equine Encephalomyelitis Diseases 0.000 description 2
- 101710154606 Hemagglutinin Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 2
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 2
- 101710176177 Protein A56 Proteins 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000000185 hemagglutinin Substances 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000003926 Myelitis Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000003711 chorioallantoic membrane Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229940124452 immunizing agent Drugs 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000563 toxic property Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36161—Methods of inactivation or attenuation
- C12N2770/36164—Methods of inactivation or attenuation by serial passage
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE554749A true BE554749A (enrdf_load_stackoverflow) |
Family
ID=179089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE554749D BE554749A (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE554749A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2051520A1 (enrdf_load_stackoverflow) * | 1969-05-13 | 1971-04-09 | Bayer Ag |
-
0
- BE BE554749D patent/BE554749A/fr unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2051520A1 (enrdf_load_stackoverflow) * | 1969-05-13 | 1971-04-09 | Bayer Ag |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0088303B1 (fr) | Procédé de préparation de complexes polysaccharide-protéine de capsules bactériennes, produits obtenus et compositions immunogènes les contenant | |
| FR2468372A1 (fr) | Nouveau vaccin contre les maladies infectieuses chez les bovins et son procede de production | |
| US4224412A (en) | Living virus culture vaccine against canine distemper and method of preparing same | |
| Vershilova | The use of live vaccine for vaccination of human beings against brucellosis in the USSR | |
| EP1159968A1 (fr) | Souches atténuées du virus de la Dengue et leur utilisation dans une composition vaccinale | |
| LU86761A1 (fr) | Compositions d'anticorps monoclonaux humains assurant la protection croisee | |
| EP0007467A1 (fr) | Vaccin antigrippal et procédé pour sa préparation | |
| FR2499410A1 (fr) | Vaccin contre l'avortement enzootique chez les brebis et son procede de preparation | |
| BE554749A (enrdf_load_stackoverflow) | ||
| FR2515518A1 (fr) | Procede de production de preparations immunobiologiques applicables pour le diagnostic, la prevention et/ou le traitement d'infections par le candida guilliermondii, et preparations immunobiologiques en resultant | |
| US3318775A (en) | Production of viral antigens with n-acetyl-ethyleneimine | |
| FR2538703A1 (fr) | Vaccin vivant pour la prevention de la salmonellose des oiseaux aquatiques et procede pour sa preparation | |
| CH382917A (fr) | Procédé pour la production d'un virus-vaccin contre la maladie des chiens | |
| US4759927A (en) | Vaccine against Potomac horse fever and method of preparation therefore | |
| FR2479000A1 (fr) | Vaccin contre la brucellose, maladie du betail | |
| EP0051522B1 (fr) | Mutant de septicémie hémorragique virale, vaccin contenant ce mutant et procédé pour sa préparation | |
| US4312947A (en) | Process for the preparation of a vaccine against panleucopenia of the cat | |
| EP0106831B1 (fr) | Souches modifiées du virus de la diarrhée virale bovine, leur préparation et vaccins les contenant | |
| RU2217163C2 (ru) | Вакцина против кандидоза сельскохозяйственных животных | |
| BE1000255A4 (fr) | Procede de preparation d'une souche de bordetella bronchiseptica mutante amelioree interessante comme vaccin vivant attenue conferant une protection contre les infections par b. bronchiseptica et vaccin ra vivant attenue que l'on en obtient. | |
| RU2741643C1 (ru) | Ассоциированная вакцина против миксоматоза, пастереллёза и вирусной геморрагической болезни кроликов 1 и 2 типов | |
| RU2084240C1 (ru) | Вакцина "микродерм" против дерматофитозов животных | |
| JPS58159423A (ja) | パスツレラムルトシダ菌株の培養による免疫抗原の製造方法 | |
| FR2571618A1 (fr) | Nouveau vaccin contre la tracheobronchite infectieuse canine et son procede de preparation | |
| KR960003898B1 (ko) | 리켓챠 쯔쯔가무시 항원의 제조방법 |